Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
International League Against EpilepsyC Seizure Aggravation in Idiopathic Generalized Epilepsies J. Chaves and J.W. Sander Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, United Kingdom Summary: Seizures in the idiopathic generalized epilep-sies (IGEs) usually remit completely with antiepileptic drugs (AEDs). Exacerbation of seizures in idiopathic generalized epilepsy has been demonstrated for several commonly used antiepileptic drugs, including vigabatrin, tiagabine, carbamazepine, and possibly gabapentin. The same drugs may exacerbate some seizure types in patients with Lennox–Gastaut syndrome . This is not surprising, as both types of epilepsy Studies have demonstrated the effectiveness of gabapentin as an adjunctive treatment for various types of seizures, including partial onset seizures and generalized tonic-clonic seizures. It has been shown to significantly reduce seizure frequency, improve seizure control, and enhance the quality of life for individuals with epilepsy. Gabapentin may be considered to decrease seizure frequency in patients aged 60 years or older with new-onset focal epilepsy. Supporting evidence: One double-blind randomized study compared efficacy and tolerability of gabapentin, lamotrigine, and carbamazepine in patients aged 60 years or older. Since gabapentin was marketed over 120,000 patients have been exposed to the drug. Clinical trial data have been largely obtained from clinical trials using gabapentin as adjunctive ther apy in medically refractory patients. It has demonstrated efficacy against partial seizures and secondarily generalized tonic-clonic seizures. Gabapentin is well tolerated by patients with generalized seizures. The results of this study show a trend toward an effect of gabapentin in reducing the frequency of generalized tonic-clonic seizures and suggest that further exploration of high dose gabapentin in generalized epilepsy is warranted. generalized epilepsy. They are gabapentin (Neuron-tin), lamotrigine (Lamictal), topiramate (Topamax), tiagabine (Gabitril), oxcarbazepine (Trileptal), leveti-racetam (Keppra), and zonisamide (Zonegran). These antiepileptic drugs were approved by the Food and Drug Administration in the last 10 years. We recog- Gabapentin is well tolerated by patients with generalized seizures. The results of this study show a trend toward an effect of gabapentin in reducing the frequency of generalized tonic-clonic seizures and suggest that further exploration of high dose gabapentin in generalized epilepsy is warranted. The children with complex partial seizures and secondarily generalized seizures showed the greatest improvement. Gabapentin is not the best add-on seizure medicine for everyone. Sometimes, a series of combinations must be tried before finding what is best for the individual. The group found that gabapentin is effective in the treatment of newly diagnosed partial epilepsy, and that lamotrigine, topiramate, and oxcarbazepine are effective in a mixed population of The International League Against Epilepsy (ILAE) recommended gabapentin as initial monotherapy of newly diagnosed, not yet treated focal seizures in adults; for focal seizures in the elderly; and for idiopathic focal epilepsy in children (Glauser 2006; Glauser 2013). The most common side effects that were reported in studies of gabapentin are drowsiness (somnolence), dizziness, problems with movement and balance (ataxia), fatigue, and rapid and uncontrolled eye movement (nystagmus) in patients with epilepsy >12 years of age and viral infection, fever, nausea and/or vomiting, somnolence, and hostility in Numerous studies have investigated the efficacy of gabapentin in epilepsy treatment. Clinical trials and retrospective studies have consistently demonstrated the beneficial effects of gabapentin in reducing seizure frequency and improving overall seizure control. Drug-induced exacerbation of seizures is a serious and common clinical problem that is often unrecognized or overlooked by the treating physician. Its occurrence appears to be related to three possible causes: an incorrect diagnosis of seizure type or syndromic form, lack of knowledge about certain The efficacy of gabapentin (Neurontin ®) in generalized seizures was evaluated in this 14 week, double-blind, placebo-controlled, parallel-group, add-on, multicenter study. A total of 129 patients with refractory generalized seizures were randomized to receive either placebo or 1200 mg/day gabapentin as add-on therapy. Seizure types are limited to myoclonic seizures, generalized tonic-clonic convulsions (GTCs), and absence (petit mal). In contrast, symptomatic epilepsy, as well called 2° generalized, is a destructive type of epilepsy in which developmental anomaly exists, and a structural defect is recognized. One guideline states that there is insufficient evidence to consider gabapentin instead of carbamazepine in patients with new-onset focal epilepsy or unclassified generalized tonic-clonic seizures. Three guidelines recommend the use of gabapentin in older adults with epilepsy. Gabapentin is available in Canada by prescription only. Known as. Neurontin. Uses. Effective against partial seizures (including secondary generalized tonic-clonic). Somewhat effective against primary generalized tonic-clonic seizures. Ineffective or worsens absence, myoclonic or tonic/atonic type seizures. How to Use It's not usually meant to be prescribed long-term, since it's a benzo so tolerance builds up and it can stop working, then it can be extremely difficult to come off. Its best use is short-term for stopping sz clusters, and for catamenial (hormonal) szs in women but for some people taking it full-time works well for them. new-onset or recurrent focal epilepsy, unclassified generalized tonic-clonic seizures, or generalized epilepsy presenting with generalized tonic-clonic seizures (1 Class II study). 9. No high-quality studies suggest clobazam, eslicarbazepine, ezogabine, felbamate, gabapentin,
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |